Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer

By    

Oncology Reports, Vol. 34, Iss. 5, 2015-01 ,pp. : 2683-2691

Spandidos Publications

Access to resources Recommend Favorite

Bioinformatics analysis of the target gene of fibroblast growth factor receptor 3 in bladder cancer and associated molecular mechanisms

By                

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 543-549

Spandidos Publications

Access to resources Recommend Favorite

Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer

By                        

Oncology Letters, Vol. 10, Iss. 5, 2015-01 ,pp. : 2753-2760

Spandidos Publications

Access to resources Recommend Favorite

Increased serum level of epidermal growth factor receptor (EGFR) is associated with poor progression-free survival in patients with epithelial ovarian cancer

By Tas Faruk   Karabulut Senem   Serilmez Murat   Ciftci Rumeysa   Duranyildiz Derya  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 631-637

Springer Publishing Company

Access to resources Recommend Favorite

Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer

By Yonemura Y.   Fushida S.   Bando E.   Kinoshita K.   Miwa K.   Endo Y.   Sugiyama K.   Partanen T.   Yamamoto H.   Sasaki T.  

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 918-923

Elsevier

Access to resources Recommend Favorite